Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/19/2001 | CN1326949A New polypeptide-human visinin analogous protein 17.27 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326948A New polypeptide-human sigma receptor 10.67 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326947A Human thymosin alpha protogene mutant synthesis, expression and use |
12/19/2001 | CN1326946A New polypeptide-ribosomal protein S1111.22 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326945A New polypeptide-zinc finger protein 79.46 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326944A New polypeptide-symplekin 8.91 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326943A New polypeptide-conjugated protein Ran BP236.85 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326942A New polypeptide-CREB conjugated protein 30.8 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326941A New polypeptide-estrogenic receptor relative protein 9,13 and polynucleotide for encoding such polypeptide |
12/19/2001 | CN1326940A New polypeptide-ribosomal protein S13, 09 and polynuclotide for encoding such polypeptide |
12/19/2001 | CN1326938A Antigene V-erb B oligonucleotide and its use |
12/19/2001 | CN1326782A About human digestive enzyme recombined protein and its preparing method |
12/19/2001 | CN1076397C Process for preparing mycobacterium primers and probes |
12/19/2001 | CN1076356C Protein having TPO activity |
12/19/2001 | CN1076204C Recombinant coccidiosis vaccines |
12/18/2001 | US6331665 Insect resistant fertile transgenic corn plants |
12/18/2001 | US6331664 Genes, when expressed in a plant, can be used to create transgenic plants having altered palmitic acid oil profiles |
12/18/2001 | US6331663 Modified full length promoters |
12/18/2001 | US6331662 Plant retroelements |
12/18/2001 | US6331661 Method for directional stable transformation of eukaryotic cells |
12/18/2001 | US6331660 Maize DIMBOA biosynthesis genes |
12/18/2001 | US6331659 Cumulus cells as nuclear donors |
12/18/2001 | US6331658 Genetically engineered mammals for use as organ donors |
12/18/2001 | US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis |
12/18/2001 | US6331618 For analytical methods such as gel electrophoresis, high-performance liquid chromatography, primer extension reactions, polymerase chain reaction (pcr), mass spectroscopy, nuclear magnetic resonance (nmr) and x-ray crystallization |
12/18/2001 | US6331617 Positively charged oligonucleotides as regulators of gene expression |
12/18/2001 | US6331616 Nucleotide sequences coding viral envelope protein; for use as diagnostic tool in detection of viral infection |
12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
12/18/2001 | US6331612 Bone morphogenic protein-16 (BMP-16) compositions |
12/18/2001 | US6331609 Fusion protein; for use in treatment of somatotropin defects |
12/18/2001 | US6331527 Promoter smooth muscle cell expression |
12/18/2001 | US6331526 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
12/18/2001 | US6331525 Targeted delivery of genes encoding interferon |
12/18/2001 | US6331524 Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy |
12/18/2001 | US6331441 For high throughput analysis of multiple analytes in complex mixtures of sample substances, combinatorial analysis |
12/18/2001 | US6331434 Nitrogen-containing silicone useful for compacting nucleic acid sequences and use for transforming cells |
12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
12/18/2001 | US6331427 Protease homologs |
12/18/2001 | US6331425 Nucleotide sequences coding enzymatic polypeptide; for use in the diagnosis and treatment of cancer, meningitis and urogenital disorders; for sequencing preferential oligosaccharides |
12/18/2001 | US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity |
12/18/2001 | US6331421 Expression vector for use as tool for efficient generation of preferential enzymatic polypeptides |
12/18/2001 | US6331419 L-glutamic acid-producing bacterium and method for producing L-glutamic acid |
12/18/2001 | US6331417 Determine amount of target nucleotide sequences in sample; mix sample with control sequences, incubate with nucleotide sequences, perform nucleotide sequence amplification, calculate amount of control and target sequences |
12/18/2001 | US6331416 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
12/18/2001 | US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein |
12/18/2001 | US6331414 Preparation of human IGF via recombinant DNA technology |
12/18/2001 | US6331411 TopA |
12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
12/18/2001 | US6331406 Human enbryonic germ cell and methods of use |
12/18/2001 | US6331399 For therapeutic, diagnostic, and research applications for the modulation of telomer reverse transcriptase expression |
12/18/2001 | US6331398 Nucleic acid ligands |
12/18/2001 | US6331397 Method for producing long DNA constructs in agarose |
12/18/2001 | US6331393 Detecting cytosine methylation and methylated cytosine/guanine aggregations; incubate genomic nucleotide sequences adjusting agent, amplify nucleotide sequences, detecting the methylated nucleotide sequences |
12/18/2001 | US6331392 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids |
12/18/2001 | US6331390 Cell-cycle regulatory proteins, and uses related thereto |
12/18/2001 | US6331304 Immunogenic composition comprising an attenuated form which is a strain of leishmania and which is transformed by a plasmid containing the gm-csf gene |
12/18/2001 | US6331303 LKTA deletion mutant of P. haemolytica |
12/18/2001 | US6331301 Isolated dna sequences which encodes amino acid sequence in protein; |
12/18/2001 | US6331140 Mobile genetic elements as tools for genetic modification of L. delbrueckii or L. helveticus |
12/18/2001 | CA2221448C Antisense oligonucleotide modulation of raf gene expression |
12/18/2001 | CA2215531C Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
12/18/2001 | CA2209298C Mpl ligand analogs |
12/18/2001 | CA2201762C Method for purifying keratinocyte growth factors |
12/18/2001 | CA2179281C Methods of identifying lymphocytes with mutator phenotypes |
12/18/2001 | CA2134478C Microfabricated detection structures |
12/18/2001 | CA2125004C Simultaneous amplification of multiple targets |
12/18/2001 | CA2088661C Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
12/18/2001 | CA2045839C Cloned n-methylhydantoinase |
12/16/2001 | CA2350976A1 Cell libraries indexed to nucleic acid microarrays |
12/14/2001 | CA2309342A1 Protein production in transgenic plant seeds |
12/13/2001 | WO2001094952A2 Methods and compositions for modulating oxidized ldl transport |
12/13/2001 | WO2001094951A2 Inhibitors of c-reactive protein induced inflammation |
12/13/2001 | WO2001094950A2 Screening of phage displayed peptides without clearing of the cell culture |
12/13/2001 | WO2001094946A2 Microarrays for performing proteomic analyses |
12/13/2001 | WO2001094638A2 Asynchronous primed pcr |
12/13/2001 | WO2001094636A2 Compositions, kits, and methods for identification and modulation of type i diabetes |
12/13/2001 | WO2001094635A2 Integrated active flux microfluidic devices and methods |
12/13/2001 | WO2001094634A2 Methods and devices for multiplexing amplification reactions |
12/13/2001 | WO2001094633A1 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods |
12/13/2001 | WO2001094630A2 Compositions and methods for array-based nucleic acid hybridization |
12/13/2001 | WO2001094629A2 Cancer gene determination and therapeutic screening using signature gene sets |
12/13/2001 | WO2001094627A2 Assay techniques based on growth stage dependent expression in c. elegans |
12/13/2001 | WO2001094625A2 Capture moieties for nucleic acids and uses thereof |
12/13/2001 | WO2001094624A1 Method to detect modulators of vegf kinase domain |
12/13/2001 | WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase |
12/13/2001 | WO2001094620A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
12/13/2001 | WO2001094617A2 Protein fragment complementation assay based on beta-lactamase |
12/13/2001 | WO2001094616A1 Protein markers for pharmaceuticals and related toxicity |
12/13/2001 | WO2001094610A2 Binary hybrid mutational vectors |
12/13/2001 | WO2001094609A1 Charge-switch nucleotides |
12/13/2001 | WO2001094607A2 High level production of p-hydroxybenzoic acid in green plants |
12/13/2001 | WO2001094604A2 Method of using dna episomes to suppress gene expression in plants |
12/13/2001 | WO2001094603A2 Method of using dna episomes to suppress gene expression in plants |
12/13/2001 | WO2001094602A2 Method to regenerate plants and uses thereof to multiply and/or transform plants |
12/13/2001 | WO2001094601A2 Hero resistance gene conferring resistance to nematodes |
12/13/2001 | WO2001094600A2 Promoters for regulated gene expression |
12/13/2001 | WO2001094599A1 Gene expression cassette and its use |
12/13/2001 | WO2001094598A2 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells |
12/13/2001 | WO2001094597A1 Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |